Literature DB >> 28776629

Valve or No Valve: A Prospective Randomized Controlled Trial of Casting Options for Pediatric Forearm Fractures.

Paul C Baldwin, Eric Han, Anthony Parrino, Matthew J Solomito, Mark C Lee.   

Abstract

The purpose of this study was to determine the rate of cast-related complications when using split or intact casts. A total of 60 patients aged 3 to 13 years with closed shaft or distal third radius and ulna fractures requiring reduction were recruited for this study. Patients underwent closed reduction under sedation and were placed into a long-arm fiberglass cast with 1 of 3 modifications: no valve, univalve, or bivalve. Patients were followed to 6 weeks after reduction or surgical treatment if required. The frequency of neurovascular injury, cast saw injury, unplanned office visits, and cast modifications, the need for operative intervention, and pain levels through the follow-up period were recorded. The results showed no incidents of compartment syndrome or neurovascular injury. Additionally, there were no differences between complications associated with cast type (P=.266), frequency of cast modifications (P=.185), or subsequent need for surgical stabilization (P=.361). Therefore, cast splitting following closed reduction of low-energy pediatric forearm fractures does not change clinical outcomes with respect to neurovascular complications, cast modifications, pain levels, or the need for repeat reduction. Consideration should be given to minimizing cast splitting after reduction of low-energy pediatric forearm fractures for practice efficiency and to potentially decrease saw-related injury. [Orthopedics. 2017; 40(5):e849-e854.]. Copyright 2017, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28776629     DOI: 10.3928/01477447-20170719-02

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  1 in total

1.  Interventions for treating wrist fractures in children.

Authors:  Helen Hg Handoll; Joanne Elliott; Zipporah Iheozor-Ejiofor; James Hunter; Alexia Karantana
Journal:  Cochrane Database Syst Rev       Date:  2018-12-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.